Previous studies have revealed the inhibitory effects of APN on NF-κB signaling in various diseases, such as Alzheimer’s disease [24], atherosclerosis [48], osteoporosis [49], and acute pancreatitis [50]. Here, NFKB1 is linked to atherosclerosis.